The deceased plaintiff in a lawsuit alleging a Wyeth-made hormone replacement therapy drug caused her death from breast cancer has a surviving identical twin who has not had breast cancer.

Both the plaintiffs and the defense attorneys sought to leverage to their advantage the fact that Cheryl Foust’s twin sister, Carol, was present and in good health in a Philadelphia Common Pleas courtroom Wednesday. Opening arguments were held in Foust v. Wyeth. Senior Judge Esther R. Sylvester is presiding over the trial.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]